Bank Of America Corp Tempest Therapeutics, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Tempest Therapeutics, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 43,257 shares of TPST stock, worth $62,290. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,257
Previous 43,029
0.53%
Holding current value
$62,290
Previous $168,000
44.05%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TPST
# of Institutions
28Shares Held
1.72MCall Options Held
30KPut Options Held
80.5K-
Black Rock Inc. New York, NY550KShares$792,3470.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA176KShares$253,7170.0% of portfolio
-
Geode Capital Management, LLC Boston, MA154KShares$222,1070.0% of portfolio
-
Fil LTD Hamilton, D0130KShares$186,5930.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX106KShares$152,0640.09% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $15M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...